Classification of current anticancer immunotherapiesLorenzo Galluzzi, Guido Kroemer, Enrico Lugli et al.|Oncotarget|2014Cited by 469
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Romain Daillère et al.|Science|2020Cited by 382
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, María P. Roberti et al.|Nature Communications|2017Cited by 201
Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D TriggeringAna I. Romero, Laurence Zitvogel, Nathalie Chaput et al.|Cancer Research|2013Cited by 40